By Counterforce Health Team in HyperHEP (hepatitis B immune globulin) —

How to Get HyperHEP (Hepatitis B Immune Globulin) Covered by Aetna CVS Health in Illinois: Forms, Appeals, and Provider Portals

Answer Box: Getting HyperHEP Covered by Aetna CVS Health in Illinois

HyperHEP (hepatitis B immune globulin) requires prior authorization from Aetna CVS Health for post-exposure prophylaxis when medically necessary. Coverage applies to percutaneous/mucosal exposure to HBsAg-positive blood, sexual contact with HBV-infected individuals, and newborns of HBsAg-positive mothers. Submit PA via Availity portal or fax 888-267-3277 within 7 days of exposure. If denied, appeal internally within 60 days, then request Illinois external review within 4 months through the Illinois Department of Insurance.

Table of Contents

  1. Verify Your Plan and Coverage
  2. Prior Authorization Forms and Requirements
  3. Submission Portals and Electronic Access
  4. Fax Numbers and Mail Addresses
  5. CVS Specialty Pharmacy Enrollment
  6. Support Lines and Contact Information
  7. Illinois Appeals and External Review
  8. Keeping Resources Current

Verify Your Plan and Coverage

Before starting the prior authorization process, confirm your specific Aetna CVS Health plan covers HyperHEP under medical benefits (not pharmacy). Log into your Aetna member portal or call the number on your ID card to verify:

  • Precertification requirements: Check the 2025 Precertification List for hepatitis B immune globulin
  • Medical vs. pharmacy benefit: HyperHEP is covered under medical benefits, not CVS Caremark formulary
  • Network requirements: Confirm your provider and administration site are in-network
Note: Emergency post-exposure treatment can often be administered immediately with retrospective PA filing, as urgent care is typically covered pending review.

Prior Authorization Forms and Requirements

Coverage Criteria

Aetna covers HyperHEP when medically necessary for CDC-approved post-exposure prophylaxis, specifically:

Covered Scenarios Required Documentation
Percutaneous/mucosal exposure to HBsAg-positive blood Exposure incident report with date, time, nature of exposure
Sexual contact with HBsAg-positive person Source HBsAg status confirmation
Newborns of HBsAg-positive mothers Maternal HBsAg results
Household exposure in infants <1 year Patient vaccination history and anti-HBs levels

Required Documentation Package

Medical Necessity Letter must include:

  • Exposure incident details (date, time, nature)
  • Source HBsAg status (positive or unknown high-risk)
  • Patient's HBV vaccination history
  • Anti-HBs antibody levels (<10 mIU/mL indicates non-immunity)
  • Citation of Aetna Policy 0544 and CDC guidelines
  • ICD-10 codes (Z20.5 for hepatitis contact)

Timing Requirements:

  • Preferred: Within 7 days of exposure per CDC guidelines
  • Acceptable: Up to 14 days with additional clinical justification
  • Emergency: Administer immediately, file retrospective PA

Submission Portals and Electronic Access

Primary Electronic Submission

Availity Provider Portal (recommended)

  • URL: aetna.com/health-care-professionals/availity.html
  • Features: PA requests, claim status, patient eligibility verification
  • Processing: >95% of eligible requests approved within 24 hours
  • Required: Electronic submission mandatory as of June 1, 2023

Alternative Portals

CoverMyMeds ePA

  • Integration with most EMR systems
  • Direct connection to Aetna PA workflow
  • Real-time status updates

Aetna Provider Web

Illinois Medicaid Note: Aetna Better Health of Illinois members access services through the Illinois Medicaid portal via Availity.

Fax Numbers and Mail Addresses

Fax Submission

Primary PA Fax: 888-267-3277

  • Include cover sheet with member ID, provider NPI, and "URGENT - Post-Exposure Prophylaxis" notation
  • Confirm receipt within 24 hours by calling provider services

Phone Authorization

Precertification Line: 866-752-7021

  • Available for urgent cases requiring immediate approval
  • Have all documentation ready before calling

Mail Submission (if required)

Check your denial notice or Aetna correspondence for specific mailing addresses, as these vary by plan type and region. Illinois-specific addresses are typically provided in denial letters.

CVS Specialty Pharmacy Enrollment

HyperHEP may require specialty pharmacy handling depending on your specific plan. Here's how to enroll:

Enrollment Process

  1. Contact CVS Caremark: Use the toll-free number on your Aetna member ID card
  2. Online enrollment: Log into your Caremark member portal
  3. Transfer existing prescriptions: CVS facilitates transfers from other specialty pharmacies

Transfer Steps

  • List current prescriptions and last fill location
  • Call CVS Specialty to initiate transfer
  • Confirm prior authorizations transfer (valid PAs are honored)
  • Verify first fill timeline and delivery options
From our advocates: One patient successfully transferred their HyperHEP prescription during an Aetna plan transition by calling both the old and new specialty pharmacies on the same day, ensuring no gap in coverage. This proactive approach prevented delays when urgent treatment was needed.

Support Lines and Contact Information

Member Support

Aetna Member Services: Number on your ID card

  • Verify benefits and coverage
  • Check PA status
  • Request expedited review

Questions to Ask:

  • "Is HyperHEP covered under my medical benefit?"
  • "What's the status of PA request [reference number]?"
  • "Can you expedite this for post-exposure prophylaxis?"

Provider Support

Aetna Provider Services: 866-752-7021

  • Clinical consultations
  • Peer-to-peer review requests
  • Appeal guidance

CVS Caremark: 1-888-792-3862

  • Specialty pharmacy questions
  • Transfer assistance
  • Prior authorization status

Illinois Appeals and External Review

Internal Appeals Process

Timeline: 60 days from denial notice Submission: Via Availity portal or written appeal to address in denial letter

Required Documentation:

  • Original denial letter
  • Updated medical necessity letter
  • Additional clinical evidence
  • CDC guidelines and Aetna Policy 0544 citations

Illinois External Review

If internal appeal fails, Illinois residents have strong external review rights:

Eligibility:

  • Medical necessity denials
  • Member financial responsibility >$500
  • Clinical judgment disputes

Timeline: Request within 4 months of final adverse determination (stricter than many states)

Process:

  1. Submit Illinois Request for External Review form to Illinois Department of Insurance
  2. IDOI assigns Independent Review Organization (IRO) within 1 business day
  3. Board-certified physician reviewer makes binding decision within 30 days
  4. No cost to consumer

Expedited Review: Available if delay would jeopardize health, with decisions in 24-72 hours

Illinois Consumer Resources

Illinois Department of Insurance Office of Consumer Health Insurance

  • Phone: 877-527-9431
  • Assistance with appeals and external reviews

Illinois Attorney General Health Care Bureau

  • Helpline: 1-877-305-5145
  • Can intervene informally with insurers

Common Denial Reasons and Solutions

Denial Reason How to Overturn Key Documentation
Not medically necessary Cite Aetna Policy 0544 and CDC guidelines Medical necessity letter, exposure report
Timing outside window Justify with clinical literature on delayed treatment Studies on HBIG efficacy beyond 7 days
Insufficient exposure documentation Provide detailed incident report Source testing, exposure circumstances
Alternative therapy available Document contraindications to HBV vaccine Allergy history, immunocompromised status

Update Cadence

Check quarterly:

Check annually:

  • Plan formulary changes (January updates)
  • Illinois insurance regulations
  • Contact information and portal access

After any denial:

  • Verify current appeal deadlines
  • Confirm submission addresses/portals
  • Check for policy updates that may support your case

About Counterforce Health: Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals. Our platform analyzes denial letters, plan policies, and clinical notes to draft point-by-point rebuttals aligned with each payer's specific requirements, pulling the right medical evidence and procedural details to maximize approval chances.

Frequently Asked Questions

How long does Aetna CVS Health prior authorization take for HyperHEP in Illinois? Standard PA decisions are made within 24 hours for >95% of eligible electronic submissions. Urgent post-exposure cases can often receive same-day approval when submitted via phone (866-752-7021) with complete documentation.

What if HyperHEP is denied as not medically necessary? Appeal with a detailed medical necessity letter citing Aetna Policy 0544, CDC post-exposure guidelines, and specific exposure circumstances. Include source HBsAg status and patient's immunity testing results.

Can I request an expedited appeal in Illinois? Yes, if delay would jeopardize your health. Submit physician certification for expedited review. Illinois external reviews can be expedited to 24-72 hours for urgent cases.

Does step therapy apply to HyperHEP? No, HyperHEP is not subject to step therapy as it's used for specific post-exposure prophylaxis situations where alternatives aren't appropriate.

What if my provider isn't in Aetna's network? For emergency post-exposure treatment, out-of-network providers may be covered at in-network rates. Request prior authorization for out-of-network exception based on urgency and lack of in-network alternatives.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies and procedures may change. Always verify current requirements with your specific plan and consult healthcare professionals for medical decisions. For official guidance on Illinois insurance appeals, contact the Illinois Department of Insurance.

Sources and Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.